Cataract

For surgeons, the decision goes beyond clarifying a patient’s vision.

Researchers have now found that subjects who underwent cataract surgery had nearly 30% lower risk of developing dementia from any cause compared with those who did not.

The novel sustained-release technology has potential to eliminate the need for eye drops after cataract surgery.

Investigators conducted a retrospective consecutive study in which they compared the outcomes using this approach with the results achieved with local anesthesia alone during cataract surgery.

Performing cataract surgery on young patients can be a challenge, and the evolving technology can be used in cataract surgery for young children.

Investigators set out to better define therapeutic options for controlling the inflammatory response and reducing the risk of pseudophakic cystoid macular edema after cataract surgery.

A web app-based personalized music intervention before cataract surgery may lower anxiety levels or reduce the need for sedative medication.

“Real talk” on new devices gives surgeons, patients decision-making insights

Ophthalmologist outlines his journey with the procedure as a late adopter.

According to investigators, the risk of death from strokes, heart attacks and other vascular causes is increased by more than a third.

Three cases demonstrate value of new tools, technology for surgeons.

Techniques, technologies minimize complications and guide counseling, care.

Factors that lead to complications must be managed for best outcomes.

Robert Weinstock, MD, discusses the efficacy and safety of intracameral dexamethasone suspension 9% compared to standard of care topical regimen for eyes receiving cataract surgery.

Cathleen McCabe, MD, shares an overview of results from a retrospective study highlighting the effectiveness of dexamethasone intraocular suspension 9% following cataract surgery.

The company will host Innovation Week from Sept. 21-23, demonstrating new data management innovations across devices, workflow solutions and software applications.

Marta Belmonte-Grau, MD discusses the potential risk for posterior capsular rupture during cataract surgery.

Early experience with next-generation lens engenders positive perception.

Understanding nuances of reimbursement for novel, sustained-release ophthalmic drugs can help maximize the opportunity for patients and practice.

Advances help gain clearer image, enhancing decision-making process.

Michael Rivers, MD, discusses the impact of Aetna's new policy requiring prior authorization for cataract surgery on ophthalmologists, their workflow, and patients.

Substantial weight loss can help patients’ eye health, study results show.

Taking control of a practice’s future with investment, creative thinking

Mark Gallardo, MD, reports 12-month outcomes of iStent inject® combined with cataract surgery in a predominantly Hispanic patient population with mild to moderate open-angle glaucoma (OAG) and comorbid cataract.